MARKET

IMNM

IMNM

Immunome Inc
NASDAQ
7.91
-0.03
-0.38%
After Hours: 7.84 -0.07 -0.89% 17:55 05/13 EDT
OPEN
8.37
PREV CLOSE
7.94
HIGH
8.37
LOW
7.84
VOLUME
1.77M
TURNOVER
--
52 WEEK HIGH
16.81
52 WEEK LOW
5.15
MARKET CAP
688.26M
P/E (TTM)
-1.5833
1D
5D
1M
3M
1Y
5Y
1D
Immunome (IMNM) Receives a Buy from Lake Street
TipRanks · 16h ago
Immunome’s Promising Pipeline and Strategic Advancements Support Buy Rating
TipRanks · 1d ago
Immunome (IMNM) Receives a Buy from TD Cowen
TipRanks · 1d ago
Immunome, Inc. (IMNM) Reports Q1 Loss, Tops Revenue Estimates
NASDAQ · 1d ago
Immunome Expands Share Reserve in Inducement Plan
TipRanks · 1d ago
*Immunome 1Q Loss/Shr 52c >IMNM
Dow Jones · 1d ago
Weekly Report: what happened at IMNM last week (0505-0509)?
Weekly Report · 1d ago
Weekly Report: what happened at IMNM last week (0428-0502)?
Weekly Report · 05/05 11:37
More
About IMNM
More
Immunome, Inc. is a clinical-stage targeted oncology company, which is focused on developing first-in-class and targeted therapies designed to improve outcomes for cancer patients. The Company is engaged in advancing an innovative portfolio of therapeutics in the design, development, and commercialization of targeted cancer therapies, including antibody-drug conjugate therapies (ADCs). Its advanced pipeline programs are varegacestat, a gamma secretase inhibitor which is in a Phase III trial for the treatment of desmoid tumors; IM-1021, an ROR1-targeted ADC which is in a Phase I trial, and IM-3050, a FAP-targeted radioligand. The Company's pipeline also includes IM-1617, IM-1335, and IM-1340, all of which are preclinical ADCs pursuing undisclosed targets with expression in multiple solid tumors. IM-1617 is a potential first-in-class ADC that targets an undisclosed receptor that is expressed in a range of solid tumors, including colorectal cancer and ovarian cancers.
Recently
Symbol
Price
%Change

Webull offers Immunome Inc stock information, including NASDAQ: IMNM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMNM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IMNM stock methods without spending real money on the virtual paper trading platform.